GuangZhou Cellgenes Biotechnology Co., Ltd.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Trial of CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Sarcopenia	Atrophy, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, nervous system disorder	Recruiting	Phase 1 / Phase 2	2026-10-08		NCT07865676
Safety and Efficacy of Allogeneic Bone Marrow MSCs in Ankylosing Spondylitis	Axial Spondyloarthritis, Spondylarthritis, Spondylarthropathies, ankylosing spondylitis, ankylosis, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, spondylitis, vertebral column disorder	Not yet recruiting	Phase 1	2026-06-08		NCT07632599

Clinical trials